|
Many colleagues have been
concerned about instructions from PCTs-SHAs or within trusts to have an
ideal benchmarked new to follow up ratio irrespective of clinical need. Dr
Rowan Hillson, National Clinical Director, has looked into this and has
issued the following statement:
-----Original Message-----
From: Rowan.Hillson@dh.gsi.gov.uk [mailto:Rowan.Hillson@dh.gsi.gov.uk]
Sent: 15 January 2009 09:46
To: peter.winocour@nhs.net
Cc: Nick.Morrish@bedfordhospital.nhs.uk; mark.edwards@thh.nhs.uk
Subject: New-to-follow up ratios
Dear Peter and colleagues, and Nick
As you see, I have been trying to find out about new-to-follow-up ratios.
Here is my answer and some of the email trail. My view is:
"Every person with diabetes deserves the highest standards of personalised
diabetes care. Follow-up arrangements agreed with each patient should be
determined by clinical need and be appropriate to that particular patient's
situation. There is no ideal follow-up to new ratio in diabetes or
endocrinology and to set one could be undermining what is best for the set
of patients that a clinic has at that time."
I am happy for you to share this statement with anyone who is interested.
With best wishes
Rowan
Dr Rowan Hillson MBE
National Clinical Director for Diabetes
Department of Health
Wellington House
London SE1 8UG
Phone 020 7972 4771
Fax 020 7972 4900 |
